|
Sign In to gain access to subscriptions and/or personal tools.
|
The Long-Term Clinical Outcome of 56 Patients with Biopsy-Proven Lupus Nephritis Followed at a Single Center
Ronald H.W.M. Derksen
Department of Internal Medicine (Div. Immunopathology), University Hospital, Utrecht, The Netherlands
Ronald J. Hené
Department of Nephrology, University Hospital, Utrecht, The Netherlands
Louis Kater
Department of Internal Medicine (Div. Immunopathology), University Hospital, Utrecht, The Netherlands
We retrospectively evaluated the clinical outcome of 45 female and 11 male patients with biopsy-proven lupus nephritis, followed at our hospital between February 1974 and February 1990. In the majority signs of nephritis were present at the time systemic lupus erythematosus was diagnosed (range: —42-156 months) and the median time from onset of nephritis to biopsy was 2 months. The median follow-up from the time of the biopsy was 53.5 months (range: 2-192), the median age at biopsy 25 years and the median serum creatinine level 1.2 mg/dl. Initial renal biopsies had the following histopathological classes according to the World Health Organization criteria (n): I (2); II (10); III (10); IV (28); V (5); VI (1). Over the study period active episodes were treated with high-dose oral prednisone alone or combined with intravenous nitrogen mustard and oral chlorambucil (1974-75), azathioprine (1978-86), cyclophosphamide (1986-90) and/or plasma-exchange (1976-84). These strategies were based on literature data or multicenter studies in which we participated.
Eight patients developed end-stage renal disease (ESRD) (median: 47 months post-biopsy; range: 20-120). In these, initial biopsies showed class IV in seven, and class V in one. Confounded risk factors for ESRD were class IV biopsy, male gender and serum creatinine level above 1.4 mg/dl. The calculated proportion without ESRD 5 years post-biopsy was 87% (95% confidence limits: 98-76%), and at 10 years 70% (95% confidence limits: 90-49%). Five patients (11.2%) died; causes of death were cerebrovascular accident (n = 2), cerebral lupus (n = 2) and S. aureus sepsis (n = I). Twelve (21.4%) patients had localized herpes zoster infection; six (10.7%) had a salmonella sepsis.
Key Words: Systemic lupus erythematosus Lupus nephritis
Lupus, Vol. 1, No. 2,
97-103 (1992)
DOI: 10.1177/096120339200100207

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Chrysochou, H. Randhawa, R. Reeve, S. Waldek, G. N. Wood, D. J. O'Donoghue, and P. A. Kalra
Determinants of renal functional outcome in lupus nephritis: a single centre retrospective study
QJM,
April 1, 2008;
101(4):
313 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Moroni, S. Quaglini, B. Gallelli, G. Banfi, P. Messa, and C. Ponticelli
The long-term outcome of 93 patients with proliferative lupus nephritis
Nephrol. Dial. Transplant.,
September 1, 2007;
22(9):
2531 - 2539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Manger, B Manger, R Repp, M Geisselbrecht, A Geiger, A Pfahlberg, T Harrer, and J R Kalden
Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus
Ann Rheum Dis,
December 1, 2002;
61(12):
1065 - 1070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I W Uthman, A A Muffarij, W A Mudawar, F W Nasr, and A-F. Masri
Lupus nephritis in Lebanon
Lupus,
May 1, 2001;
10(5):
378 - 381.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A Y. Wang, P K. Li, F M. Lai, K M Chow, C C Szeto, C B Leung, and S F Lui
Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese
Lupus,
April 1, 2001;
10(4):
295 - 298.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Font, M. Ramos-Casals, R. Cervera, M. Garcia-Carrasco, A. Torras, A. Siso, A. Darnell, and M. Ingelmo
Cardiovascular risk factors and the long-term outcome of lupus nephritis
QJM,
January 1, 2001;
94(1):
19 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakano, M. Ueno, H. Hasegawa, T. Watanabe, T. Kuroda, S. Ito, and M. Arakawa
Renal haemodynamic characteristics in patients with lupus nephritis
Ann Rheum Dis,
April 1, 1998;
57(4):
226 - 230.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C.A. Arce-Salinas, A.R. Villa, J.O. Martinez-Rueda, L. Munoz, M.H. Cardiel, J. Alcocer-Varela, and D. Alarcon-Segovia
Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study
Lupus,
June 1, 1995;
4(3):
197 - 203.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lopez Dupla, M. Khamashta, V. P. Garcia, P. L. Uriol, E. V. Ortega, and A. Gil Aguado
Malignancy in Systemic Lupus Erythematosus: a Report of Five Cases in a Series of 96 Patients
Lupus,
December 1, 1993;
2(6):
377 - 380.
[Abstract]
[PDF]
|
 |
|
|
|